Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Impact of a diagnostic bronchoscopy service with embedded reflex molecular testing within an oncology centre in patients with lung cancer: The Bronchiomics study. This is an ASCO Meeting Abstract from ...

Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...

SINGAPORE—For many patients across Asia, a cancer diagnosis often begins a difficult search, not only for treatment, but for ...

CLINTON, Wash. — James DeLong was 51 years old and physically fit when he received devastating news in 2001: prostate cancer. "I'm swallowing hard because, you know, I was like, well, in five years, I ...

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...

Prostate cancer is one of the top diagnoses for men with cancer, but early stages are tough to detect.